Aktieanalys

Transtema Q3 2022: Impressive organic growth - Redeye

{newsItem.title}

Redeye Publicerad: 03 Nov 2022 09:13

Redeye retains its positive view on Transtema following its Q3 2022 report revealed earlier today, where both sales and EBITA clearly beat our expectations with strong organic growth. Consequently, we will likely make forecast adjustments slightly affect our valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/861161/transtema-q3-2022-impressive-organic-growth?utm_source=finwire&utm_medium=RSS

Nyheter om Transtema

Läses av andra just nu

Om aktien Transtema

Senaste nytt